Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. hyscreen

HYscreen

A fast, cost-effective breath analysis technology for Helicobacter pYlori screening at both large and small scale.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 HYscreen project word cloud

Explore the words cloud of the HYscreen project. It provides you a very rough idea of what is the project "HYscreen" about.

cancer    infection    oxidizer    ulcers    simplicity    answering    simpler    helicobacter    lymphoma    ulceration    tests    bill    gastric    duodenal    protection    time    usa    bedfont    incidence    oxide    though    lower    66    innovation    validation    diagnostic    too    accuracy    endoscopies    infections    diagnosis    ultimately    expensive    optimizing    detects    global    convenience    secondary    shorten    quicker    healthcare    clinical    aesthetics    trials    solution    primary    pylori    final    hyscreen    screening    feasibility    scientific    cheaper    population    commercially    fast    breath    urea    expertise    offers    ltd    care    sensor    treatment    prototype    decisions    link    air    asia    give    ammonia    monitoring    optimization    inconvenient    affordable    entrapment    costly    exhaled    nitrogen    sampling    invasive    market    respectively    mouthpiece    reduce    close    absorption    diagnostics    preventing    rapid    avoiding    savings    c12    biomarker    business    realized    solutions    portable    device    consequently    billion    impetus    plan    thermal    programs    biopsies    doors    unnecessary   

Project "HYscreen" data sheet

The following table provides information about the project.

Coordinator		 Bedfont Scientific Limited 

Organization address
address: Station Yard, Station Road
city: Maidstone
postcode: ME17 1JA
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country United Kingdom [UK]
 Project website https://www.bedfont.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2014
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-05-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    Bedfont Scientific Limited UK (Maidstone) coordinator 50˙000.00

Map

 Project objective

The increasing incidence of Helicobacter (H.) pylori infections and their close link with gastric cancer, gastric lymphoma, duodenal and gastric ulceration, give impetus to the H. pylori diagnostics market. Existing solutions are too costly, inconvenient and invasive; have a long analysis time or need technical expertise to analyse. Bedfont Scientific Ltd offers a portable H. pylori diagnostic device, HYscreen, which detects ammonia in exhaled air as a biomarker for H. pylori. It has a rapid diagnosis, higher accuracy, lower cost, greater simplicity and convenience. It has the following innovation features: a mouthpiece breath entrapment sampling system, a thermal oxidizer and a Nitrogen Oxide (NO) sensor. This solution is aimed at primary and secondary care in Europe and USA and population screening programs in Asia, answering the call for a cheaper, quicker and simpler monitoring device. This will lead to improved clinical decisions that will facilitate early treatment of the infection, preventing H pylori related cases of gastric cancer and gastric or duodenal ulcers. Consequently, Europe-wide and global savings of up to €1.5 billion and €5.66 billion respectively will be realized by avoiding unnecessary endoscopies, biopsies, expensive H. pylori tests and the healthcare bill from H. pylori-related conditions. Ultimately, HYscreen will open doors for fast and affordable population wide screening. The test will use cheaper C12 urea, though work still needs to be done to make it commercially available. There is a challenge to shorten the thermal oxidizer system for better aesthetics and to reduce ammonia absorption. In Phase 1, we study the feasibility of optimizing the thermal oxidizer system, the use and optimization of C12 urea, protection of the product and the detailed business plan. Phase 2 will produce the final product from the prototype along with the validation steps and clinical trials.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "HYSCREEN" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "HYSCREEN" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

INADVANCE (2019)

Patient-centred pathways of early palliative care, supportive ecosystems and appraisal standard

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More  

INTE-AFRICA (2019)

Integrating and decentralising diabetes and hypertension services in Africa

Read More